About
Engineer by heart, entrepreneur, and investor. Passionate about enabling high-impact…
Activity
5K followers
-
Daniel Karsberg reposted thisDaniel Karsberg reposted this"If you want to be serious in life science venture capital, you need to have a multi-year perspective" Björn Odlander has taken that view for 30 years. Since he co-founded HealthCap, companies it backed have brought 35 approved drugs to market. Now he wants Europe's pension funds to take the same long view. Today they invest only a very small fraction of their assets in venture capital, and too often, he argues, their money ends up financing innovation in the US instead. "Pensions are not paid by financial returns on financial markets. They are paid by growth in the economy," he tells Nordic Life Science. Read the full interview by Gustav Ceder 👇 Photo: Lars Pehrson and Dan Coleman https://lnkd.in/d_ZFBMpX
-
Daniel Karsberg shared thisGreat work by the CurifyLabs team! 1 million individual doses is a powerful milestone! The ability to make personalized medicine scalable will ultimately improve care for millions of patients globally!Daniel Karsberg shared thisOne million. That's how many units have now been printed across our customers using CurifyLabs printers. It's a milestone we're incredibly proud of—not just because of the number itself, but because every printed unit represents a patient-specific treatment prepared when and where it was needed. This achievement wouldn't have been possible without the trust of our customers, the dedication of our team, and the collaboration of partners who believe that pharmaceutical manufacturing can be more flexible and more personalized. Thank you to everyone who has been part of this journey. Here’s to the next million! #3DPrinting #PersonalizedMedicine #NonSterileCompounding #HealthcareInnovation #CurifyLabs
-
Daniel Karsberg posted thisThe FDA considers assessing generative-AI-enabled medical devices like doctors. When I reviewed the list of FDA-approved AI-enabled medical devices, a list that is growing rapidly, I could find only 1 approved device using generative AI (i.e. LLMs). Accelerating innovation using generative AI would require a transformation of regulatory systems. Yesterday, the FDA published a consideration and a request for public input on a new framework around regulating generative AI-enabled medical devices. The paper outlines a risk approach where risk, and hence regulatory requirements, increase the more 'action-directing' a device function is. It aims at differentiating between functions that somewhat guide clinicians and decision-making. I find the paper interesting, as founders and investors building for healthcare need direction. Not least because generative AI already entered the sector, sometimes without clear regulatory guidance. The idea of verifying safety and building out a postmarket monitoring process that depends on the level of 'action-directing' functionality is start. Keen to follow the process.
-
Daniel Karsberg posted thisAutomation bias is an underappreciated risk in AI in general, but in clinical AI in particular. The risk is that the more reliable a system looks, the less people check it. There are multiple published studies on the phenomenon, and it has implications for how clinical AI companies need to design their products to ensure critical thinking and to challenge the model's replies as a process step. A model that's known to be accurate ends up trusted more blindly than one that's wrong more often. So far so good? Well, the twist is that better models make errors more difficult to spot, and since LLMs aren't 100% correct all the time (far from it), a user could end up making the same number of errors, or more, when using a high-performing model. In clinical AI, errors typically occur when diagnosing edge cases requiring experience and deep domain expertise, and they could have severe consequences.
-
Daniel Karsberg shared thisGoogle DeepMind just published a paper that reframes how we should think about training clinical AI. And the results are pretty interesting. Their new framework, ResidencyRL, trains AI agents the way hospitals train doctors. Instead of drilling the model on static medical exam questions, the agent practices with simulated patients in interactive, multi-turn clinical scenarios. It learns when to probe further, when to use a diagnostic tool, and critically, when to stop, avoiding what clinicians call "premature closure." This matters because it addresses something I keep coming back to: most clinical AI studies still don't look like actual clinical work. Nearly half of the 500+ medical AI studies reviewed in the recent Stanford/Harvard report used exam-style questions. Only about 5% used real patient data. We have been testing AI the way we test medical students on paper, not the way medicine actually happens.
-
Daniel Karsberg shared thisA study of the impact of vaccine benefits for children. Measles vaccines have provided children with roughly 5 billion life years gained. And yet, the US is now experiencing its highest measles case count in 30 years.
-
Daniel Karsberg shared thisExcited to join forces with the team at CurifyLabs alongside our friends at Sandwater and Tesi, and together with existing investor Lifeline Ventures. What Dr. Niklas Sandler, PhD, Charlotta Topelius and team have built is a compelling example of Finnish deep tech at its best, combining intelligent hardware and software to enable precision medical technology at a global scale, with an existing footprint in 10+ markets. We have been impressed by the founders’ deep expertise, relentless execution, and ambition, and we are excited to support them as they take CurifyLabs to the next stage of growth!Daniel Karsberg shared thisCurifyLabs raises $14M Series A to power the future of personalized medicine. 🎉 We're thrilled to announce the close of our $14M Series A, co-led by Sandwater and HealthCap, with participation from Tesi (Finnish Industry Investment Ltd) and existing investors including Lifeline Ventures — as well as many US customers and employees who believe in what we're building. Today, pharmacies in 21 U.S. states and across Europe use our Compounding System Solution to compound and dispense thousands of personalized doses every day — combining proprietary software, GMP-manufactured excipient bases, and 3D printing to deliver tailored medications with greater precision and speed than manual compounding. This funding will help us expand U.S. operations, strengthen our supply chain, enhance customer support and accelerate product innovation. Here's what our investors say: 💬 "CurifyLabs has built something rare — technology that combines clinical rigor with the speed and precision that busy pharmacy teams depend on." — Morten E. Iversen, Partner, Sandwater 💬 "What sets the best founders apart is their ability to combine scientific depth with real-world execution. The CurifyLabs team has done exactly that." — Daniel Karsberg, Partner, HealthCap 💬 "CurifyLabs is the kind of company we want to support — innovative, globally ambitious, and built on deep scientific expertise." — Joni Karsikas, Investment Director, Tesi Thank you to our investors, customers, and team for making this milestone possible! #PersonalizedMedicine #HealthTech #SeriesA #Compounding #PharmacyInnovation #3DPrinting Dr. Niklas Sandler, PhD Charlotta Topelius
-
Daniel Karsberg shared thisPacked rooftop event in Stockholm tonight, but great to catch a few minutes with Ebba Busch discussing how Sweden can better support founders and investors. It has never been more important to enable companies to attract and incentivize top talent, and to unlock capital across every stage of the startup journey. Sweden has a unique window of opportunity to implement better policies to boost the current wave of technology companies, and it is time to seize it and lead Europe!
-
Daniel Karsberg shared thisIt’s fascinating to watch how AI is entering healthcare. What stands out immediately is the industry’s deep commitment to evidence and accuracy. Unlike many sectors dominated almost entirely by speed, healthcare demands proof: demonstrating that products truly work and deliver the value they promise. That rigor creates complexity such as regulatory pathways, clinical validation, and integration challenges, but it also builds real trust. For founders, this raises the bar. Navigating healthcare requires patience, credibility, and a strong understanding of the ecosystem. But for those who do it well, the upside is enormous. Medtech markets are global and massive, yet historically difficult to scale in. Fragmented systems, complex integrations across EHRs, and regulatory hurdles have slowed adoption. I believe we’re approaching a shift. Agentic AI has the potential to fundamentally change how systems interact, enabling interoperability across fragmented platforms and helping organizations navigate regulatory complexity more effectively. It is already happening, the barriers that have defined healthcare innovation for decades have started to fall. I had a great chat with Marko Kuisma, Frida Schain, Ruth Brännvall and my friend Magnus Bergman whom I have been investing alongside in this space for almost a decade.Daniel Karsberg shared thisAI in MedTech: Revolutionary Transformation or Just Another Hype Cycle? 🧬🤖 The integration of AI within the Life Science sector has rapidly shifted from a futuristic vision to a cornerstone of industry debate. But as the dust begins to settle, a critical question remains: are we witnessing a genuine transformation in healthcare delivery and diagnostics, or are we simply riding a hype cycle destined for correction? At the recent MedTech Summit, a panel of leading investors – including Daniel Karsberg (HealthCap), Magnus Bergman (Luminar Ventures), Frida Schain (Sciety), and Ruth Brännvall (Impact Invest) – sat down with moderator Marko Kuisma to dissect the reality behind the "AI buzz". 🎥 Watch the full panel discussion at https://lnkd.in/eA49QkkD
-
Daniel Karsberg liked thisDaniel Karsberg liked thisMany thanks to @Nanna Lüneborg, @Nina Rawal and @Peter Svennilson for a great discussion today at ABI Sweden on what makes biotech worth backing – and how investing in great science can generate tremendous impact for patients and society. Thanks to ABI, in collaboration with Nobel Prize Outreach, for bringing this great conference to Stockholm, building on Sweden’s and the Nordics’ long tradition of turning world-class science into meaningful innovation and new medicines. #ABISweden #NobelPrizeOutreach #Biotech #LifeSciences #Innovation #VentureCapital #Stockholm #Nordics
-
Daniel Karsberg reacted on thisTips från coachen för husfridens skull…. Nämn alltid din svärmor i positiva ordalag när media hör av sig. ”Kom ihåg var ni hörde DET först”!:) Tack till Impact Loop 🇸🇪Daniel Karsberg reacted on this🌱 I Sveriges Radios program Spanarna hyllades ett "helt nytt, ännu mycket litet" svenskt bolag vars "kärlekshormon" ger större potatisar och godare tomater. Bolaget namngavs aldrig, men vissa lyssnare kopplade direkt. "Roligt att folk får upp ögonen för oss", säger Letavis medgrundare och ordföranden Gustav Nadal till Impact Loop. Med Dinesh Nayar. Läs mer här: https://lnkd.in/eqpgrg8f
-
Daniel Karsberg reacted on thisDaniel Karsberg reacted on thisVi tänker nytt! Sedan vår lansering för snart fem år sedan har vi bekräftat att det går alldeles utmärkt att sälja laddbara begagnade bilar online. Vi är lika säkra på att det går att sälja nya bilar. Därför är vi oerhört glada för att idag kunna gå ut med nyheten att vi inom kort börjar sälja Omoda och Jaecoobilar. Nya märken för den svenska marknaden, men redan oerhört starka i stora europeiska marknader. Full fart framåt! https://lnkd.in/d2yXP5ERCarla tar steget från begagnat till nytt - blir en av…Carla tar steget från begagnat till nytt - blir en av…
-
Daniel Karsberg reacted on thisDaniel Karsberg reacted on thisThe #stockholm techscene is becoming more and more the Silicon Valley of Europe, and yes we are also getting the mysterious morning fog 😉 Luminar Ventures Magnus Bergman Reid Jackson Louise Hagen Anders Nygren are coming over to SF together a dussin of our portfolio companies early October. Pls reach out to them if you want hook up with them bring the best of the Nordics over….our guy Rikard Steiber is as always on the ground for local coordination
-
Daniel Karsberg liked thisDaniel Karsberg liked thisVi søger en svensktalende Account Executive, der vil være en central del af vores vækstrejse i Sverige. Er det dig, eller en du kender? 🇸🇪 https://lnkd.in/eJ3_n6CG
-
Daniel Karsberg reacted on thisDaniel Karsberg reacted on thisReally great article on sifted.eu today about us at Luminar Ventures and the fact that we have topped the ranks now for 2 straight years driven by our exceptional founders, hard working and talented team and our own entrepreneurial way of driving Luminar. Thx Jonathan Sinclair for a good talk and article. Magnus Bergman Louise Hagen Reid Jackson Eira Tobrand Irene Ardenstedt Anders Nygren Rikard Steiber https://lnkd.in/daAchAdTInside Luminar Ventures, the Nordics' early-stage deal sourcing machineInside Luminar Ventures, the Nordics' early-stage deal sourcing machine
-
Daniel Karsberg liked thisDaniel Karsberg liked thisI don't know whats in the air at The Drop in Malmö, but Pale blue dot you are doing something really good. Super energized after days filled with conversations about how electrification and AI are creating a new wave of electricity demand in Europe. EV growth is exponential (and is really anyone thinking not everyone of us will have an EV soon?!), also heat pump growth is back again after the Iran crisis. Energy demand is booming, and the good news is that so is supply. Also so inspiring to hear about all the AI developments within companies. EVERYTHING is changing. The playbook is out the window. I heard quotes like: "Astra is the best software architect I have ever worked with" "The sales team is using more tokens now than the dev teams" "We are not reviewing code anymore, agents are talking to agents to solve problems" (yes also scary given the well-needed AI security discussion) All of this that gets me fired up. I want to keep on building Endeit Capital into this new world, and I want to keep on investing in the absolute best teams out there. This is fun.
Experience
Education
Projects
Languages
-
Swedish
-
-
German
-
-
Norwegian
-
-
English
-
Other similar profiles
Explore more posts
-
Ludvig Hambraeus
🔔Last week to apply for Nordic Innovation House - Silicon Valley’s REACH program. As someone who’s helped scale European business stateside, I know how there are a million things you can get wrong that will derail your expansion. Luckily, there are only a few things you have to get right to be set up for success. Even better: REACH will teach you all the tips and tricks you need to get there. Are you an innovative, Swedish tech start-up looking to the US market eventually? Apply!
-
DigitalWell Ventures
Accelerator Cohort No. 9 – MediQueue Solutions AB 🚀 “Emergency care should be transparent and efficient – for both patients and staff.” As part of DigitalWell Ventures’ accelerator, we’re introducing the ten startups shaping the future of digital health – this time with MediQueue Solutions AB, part of both our accelerator and incubator, making emergency care more human, data-driven, and efficient. Emergency departments around the world face overcrowding and long waiting times, creating stress for both patients and healthcare professionals. MediQueue was founded to bring clarity to this chaos – helping hospitals visualise real-time patient flow and waiting information. The digital tool integrates seamlessly with existing hospital systems, improving communication between patients and staff while helping hospitals make better, data-driven decisions to optimise resources. The result? Shorter waiting times, less stress, and more transparent emergency care for everyone involved. Curious to see how it works? Check out MediQueue’s short explainer video in the comments. 👇 📍 The program wraps up with Demo Day on November 26 in Oslo – when all startups step into the spotlight to pitch their progress and connect with the Nordic health tech community. We’ll be there to celebrate their journey and the shared passion for a stronger digital health future. Stay tuned – we’ll soon introduce the next startup shaping the future of digital health.
2 Comments -
Luke Pappas
Last week at TechBBQ Mikkel teased us with a hint about spektr 3.0. And now it is live! This is the next major milestone in Spektr's grand plan and another huge step forward for the compliance industry. 3.0 is three new products: First is the Policy Engine. It takes your internal policies, work instructions, SOPs, and turns them into systematic ways to define and control processes and workflows on the platform. Second is Transaction Monitoring. Other platforms still do this in a very rule-based, old-school way. Spektr merges KYC and transaction data into one platform that you control. Third is Case AI. Mundane queues of manual work get an AI first pass, so analysts can focus on what actually matters. Onboarding, monitoring, and resolution, all in one system, completely governed by your policies. Product can keep moving, operations can scale, and compliance stays in complete control. That is Spektr 3.0. In addition to leading a best-in-class AI company, Mikkel also has an increasingly obvious talent in front of the camera, and yesterday, he put that on display playing a NASA Launch Director to introduce the Spektr 3.0 launch. Tune in below to see the highlights! Mikkel Skarnager Ciprian Florescu Jeremy Joly Jan-Erik Aabo Wagner Kemi Odusan Felix Mayer Philip Chopin Elie de Fressenel Alexa Grabelle Tom Wilson Alexander Viterbo-Horten Dominik Esen Maxine Rior New Enterprise Associates (NEA) Seedcamp PSV Northzone
3 Comments
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More